Data / Form D filings / Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc.: Form D filings
Aragon Pharmaceuticals, Inc., a pharmaceuticals company in San Diego, CA, filed 5 Form D notices with the SEC between 2009 and 2012. The latest, on September 25, 2012, reports $50 million sold of a $50 million offering to 9 investors.
Find out what Aragon Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12780 EL CAMINO REAL, SUITE 301, San Diego, CA, 92130
- Phone
- (858) 369-7600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1463270
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2012 | New notice | $49,999,988 | $49,999,988 | $0 | 9 | Sep 14, 2012 | sec.gov |
| Aug 2, 2012 | Amendment | $42,233,347 | $37,800,009 | $4,433,338 | 8 | Feb 24, 2012 | sec.gov |
| Mar 7, 2012 | New notice | $42,033,346 | $37,700,007 | $4,333,339 | 7 | Feb 24, 2012 | sec.gov |
| Apr 26, 2010 | New notice | $21,999,998 | $12,000,001 | $9,999,997 | 4 | Apr 14, 2010 | sec.gov |
| May 27, 2009 | New notice | $8,000,000 | $4,000,000 | $4,000,000 | 3 | May 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Faheem A. Hasnain | Director | |
| Brett A. Zbar | Director | |
| Isan A. Chen | Executive Officer | |
| Leo A. Guthart | Director | |
| Carl A. Gordon | Director | |
| Peter A. Svennilson | Director | |
| Richard A. Heyman | Executive Officer, Director | |
| Robert A. Adelman | Director | |
| Carol A. Gallagher | Director | |
| Angie A. You | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 24, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aragon Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.